Document is current
Any future updates will be listed below
-
Authors
Claiborne, Daniel T. https://orcid.org/0000-0002-2091-1456
Detwiler, Zachary https://orcid.org/0000-0002-2218-7334
Docken, Steffen S. https://orcid.org/0000-0003-3771-5504
Borland, Todd D.
Cromer, Deborah https://orcid.org/0000-0002-5276-5094
Simkhovich, Amanda
Ophinni, Youdiil https://orcid.org/0000-0001-9443-1538
Okawa, Ken
Bateson, Timothy
Chen, Tao
Hudson, Wesley
Trifonova, Radiana
Davenport, Miles P. https://orcid.org/0000-0002-4751-1831
Ho, Tony W.
Boutwell, Christian L. https://orcid.org/0009-0005-4715-6920
Allen, Todd M.
- License Information
-
More Information
Article History
Received: 13 May 2024
Accepted: 2 January 2025
First Online: 7 January 2025
Competing interests
: ZD is a current employee, holds stock and stock options in CRISPR Therapeutics AG. TB and TH are former employees and shareholders of CRISPR Therapeutics AG. The other authors declare no competing interests.
